Allergy Research Group

Allergy Research Group

Hypoallergenic supplements backed by research

Overview

Allergy Research Group makes hypoallergenic dietary supplements using pure raw materials. They source ingredients and develop formulations designed to minimize allergen exposure, backed by scientific research. The products deliver nutrients or bioactive compounds in hypoallergenic forms and follow strict quality controls to avoid common allergens and contaminants. The company differentiates itself through its long history (since 1979), emphasis on hypoallergenic ingredient profiles, and evidence-based formulation rather than relying on trend-driven products. Its goal is to provide safe, effective nutritional supplements for people with allergies or sensitivities that support health without triggering allergic reactions.

Significant Headcount Growth

About Allergy Research Group

Simplify's Rating
Why Allergy Research Group is rated
C+
Rated C on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Healthcare

Consumer Goods

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

South Salt Lake, Utah

Founded

1979

Get referred to Allergy Research Group

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • ARG’s website updated August 6, 2026, signaling active merchandising and brand upkeep.
  • The February 2026 publication gives sales teams a fresh clinical talking point.
  • WM Partners’ 2023 ownership can fund product development, distribution, and UK Nutri-Link expansion.

What critics are saying

  • SupplementChecker lists two FDA recalls and one adverse event report as of April 2026.
  • A quality-control slip in allergy-focused products destroys practitioner trust faster than marketing rebuilds it.
  • ARG depends on a narrow practitioner channel; losing key prescribers would crater sales quickly.

What makes Allergy Research Group unique

  • Since 1979, ARG has sold hypoallergenic supplements through the healthcare practitioner channel.
  • WM Partners bought ARG in July 2023, giving it dedicated private-equity capital.
  • ARG published a peer-reviewed endocrine paper on February 4, 2026, strengthening scientific credibility.

Help us improve and share your feedback! Did you find this helpful?

Growth & Insights and Company News

Headcount

6 month growth

5%

1 year growth

5%

2 year growth

5%
FinSMEs
Jul 7th, 2023
WM Partners acquires Allergy Research Group

WM Partners, a certified diverse-owned private equity firm focused on investing in middle market companies and driving value creation in the health and wellness sector, today announced that HPH III Investments, LP, together with its parallel and feeder funds (“HPH III”), through its wholly owned entity, has acquired Allergy Research Group, a subsidiary of KI NutriCare (“KIN”), from Kikkoman Corporation.

PitchBook
Jul 7th, 2023
Global PE deals for July 7, 2023 | PitchBook

WM Partners has acquired Allergy Research Group, a hypoallergenic supplement retailer founded in 1979, from Kikkoman subsidiary KI Nutricare.

PR Newswire
Jul 6th, 2023
WM Partners announces acquisition of Allergy Research Group

WM Partners announces acquisition of Allergy Research Group.

Recently Posted Jobs

Sign up to get curated job recommendations

Allergy Research Group is Hiring for 9 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →